FUL.L Regulatory News (FUL)

12 May 2006 07:01

Fulcrum Pharma PLC12 May 2006 For immediate release 12 May 2006 FULCRUM PHARMA PLC ("the Group" or "the Company") Official Opening of Edinburgh Office to Serve Growing European Customer Base Fulcrum Pharma plc (AIM: FUL), the drug development and strategic outsourcingservices company, is pleased to announce that it has opened an office inEdinburgh with the assistance of a grant of up to £150,000 from the ScottishExecutive as part of the Group's planned expansion. The Edinburgh office, which is located at the Heriot-Watt University ResearchPark, will complement Fulcrum's other UK offices in Hemel Hempstead,Hertfordshire, and Midhurst, Kent, and its office in Strasbourg, France, andwill allow the Group to further develop the depth of the Group's resources indrug development, project management and regulatory affairs. Staff recruitment has already begun at the Edinburgh office and Fulcrum isbenefiting from both the pool of experienced talent in the region and frompeople who are relocating to the Edinburgh area. The opening of the Edinburgh office is part of the Group's planned expansion,which is seeing Fulcrum increase both the range of its services and the volumeof work it is able to carry out for its international client base. Jon Court, Chief Executive of Fulcrum Pharma, said: "I am very pleased with theopening of the Edinburgh office, which fulfils a strategic objective in that itallows scale-up of our business at a time when the outsourcing of drugdevelopment is enjoying increasing prominence in the biotechnology andpharmaceutical industries." FOR FURTHER INFORMATION, PLEASE CONTACT: Fulcrum Pharma PLC Tel: 0870 710 7152Jon Court, Chief Executive Buchanan Communications Tel: 020 7466 5000Mark Court / Mary-Jane Johnson This information is provided by RNS The company news service from the London Stock Exchange